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Introduction {#sec1}
============

Cardiovascular diseases rank the first in cause of death, which account for ∼30% of all deaths worldwide ([@bib43]). Unlike robust cardiac regeneration observed in adult zebrafish and embryonic and neonatal mice ([@bib48], [@bib49], [@bib57]), adult mammalian hearts are proposed to be postmitotic ([@bib52]) and possess extremely low renewal potency (no more than 1%--2% per year) ([@bib63]). Thus, the human heart is scarcely able to compensate the lost cardiomyocytes after heart failure ([@bib7], [@bib35]). Promising therapeutic strategies to cure the injured heart include activation of endogenous cardiac progenitor/stem cell differentiation, stimulation of pre-existing cardiomyocyte proliferation via administration of chemical compounds, modified mRNAs, genes, and recombinant proteins ([@bib17], [@bib53], [@bib68]), and transplantation of cardiac progenitor/stem cells/cardiomyocytes ([@bib53]). For the application of cardiomyocyte-based therapy to humans in the clinic, it is essential to clearly understand molecular mechanisms of differentiation from various cell sources to functional cardiomyocytes.

Several approaches have been established in mouse and human to obtain functional cardiomyocytes, including directed reprogramming of fibroblasts to cardiomyocytes using developmental transcription factors, such as GATA4, MEF2C, and TBX5, in mice ([@bib30]), activating resident stem or progenitor cells by WT1/THYMOSIN to induce the proliferation of endogenous cardiomyocytes in mice ([@bib55]), and inducing differentiation of cardiomyocytes from embryonic stem cells in humans ([@bib14]) or induced pluripotent stem cells (PSCs) from human fibroblasts and patients with heart failure ([@bib11], [@bib19], [@bib70]). Nevertheless, there are many factors and pathways, including genetic and epigenetic regulations ([@bib12]), which affect regenerative function of these cells. Establishment of novel differentiation models will undoubtedly help our understanding of molecular mechanisms of cardiomyocyte differentiation.

Zebrafish hearts can rapidly regenerate without scarring after 20% ventricular resection ([@bib49]). Thus, zebrafish cardiac muscle differentiation is an ideal model for the interpretation of molecular mechanisms of cardiac regeneration in the mammalian heart. Recently, several factors and pathways in the regulation of cardiomyocyte regeneration have been identified in zebrafish, such as Caveolin-1, Cdk9, nuclear factor κB, Telomerase, Neuregulin 1 (Nrg1), microRNA-101a, and bone morphogenetic protein signaling ([@bib5], [@bib6], [@bib13], [@bib20], [@bib32], [@bib42], [@bib62], [@bib65]). Contractile cells were first observed under spontaneous differentiation conditions in vitro using late-gastrula cells ([@bib29]). Heart aggregates were generated spontaneously, in vitro, from larval zebrafish 3 days post fertilization with an efficiency of 0.4 heart aggregate per larval fish ([@bib21]). Furthermore, several questions remain open, such as which conditions are required for efficient in vitro cardiomyocyte differentiation and whether cardiomyocyte-like cells produced in vitro are functional. Therefore, systematic modeling of cardiomyocyte differentiation with high efficiency is especially necessary in zebrafish. In this study, we established a rapid and efficient method for cardiomyocyte differentiation from zebrafish primary embryonic cells after determination of their pluripotency timing at different developmental stages. Crucial factors affecting in vitro generation of cardiomyocytes were then characterized. Contractile kinetics and sarcomere formation were also investigated. Lastly, functional electrophysiological features of beating cell clusters (BCCs) were identified. These findings are valuable for the development of high-throughput strategic screening of agents for drug discovery, disease modeling, and assessment of cardiotoxic agents, in addition to dissecting the molecular mechanisms of heart development and regeneration.

Results {#sec2}
=======

Pluripotency Timing of Early Embryonic Cells in Zebrafish {#sec2.1}
---------------------------------------------------------

To determine the pluripotency of embryonic cells in zebrafish, we first detected the morphological changes in early embryonic cells at different developmental stages ([Figures 1](#fig1){ref-type="fig"}A and 1B). Calabash-like cells with a large cell size were clearly observed before dome stage in early embryonic cells ([Figure 1](#fig1){ref-type="fig"}B). The cells became gradually smaller in size until the stage of 50% epiboly. Notably, a cytoplasmic promontory was observed in all stages of development, indicating an asymmetric spread of the cytoplasm. We then performed expression analysis of both pluripotency and germ layer markers in primary embryonic cells in zebrafish at different developmental stages ([Figure 1](#fig1){ref-type="fig"}C). RT-PCR showed that pluripotency markers *pou5f3* (POU domain class 5 transcription factor 3, also called *oct4*) and *nanog* (Nanog homeobox) were expressed at all stages, implying both maternal and zygotic expressions, while *klf17* (Kruppel-like factor 17, also called *klf4b*) started to express at the high stage (3.5 hr post fertilization \[hpf\]), indicating an expression pattern after zygotic genome activation. To determine the stage of embryonic cell differentiation, we further investigated gene-expression patterns of three germ layers (ectoderm, mesoderm, and endoderm) ([Figure 1](#fig1){ref-type="fig"}C). Both ectoderm marker *sox2* (*SRY* box 2) and endoderm marker *foxa2* (forkhead box A2, also known as *hnf3b*) were expressed from the stage of 30% epiboly (4.9 hpf), while mesoderm marker *ta* (T brachyury homolog a, also known as *ntla*) was detectable from the oblong stage (3.9 hpf). Gene-expression patterns of germ layer markers together with asymmetric spread of the cytoplasm suggested that differentiation of cell lineages in zebrafish embryos occurs as early as the oblong stage. Thus, zebrafish embryonic cells undergo a very short pluripotent state from zygotic genome activation to a brief moment after the oblong stage.

Efficient Cardiomyocyte Differentiation from Primary Embryonic Cells {#sec2.2}
--------------------------------------------------------------------

To develop an efficient method for in vitro cardiomyocyte differentiation using primary embryonic cells in zebrafish, we identified four groups of factors that all affected generation efficiency of BCCs, including coating materials, developmental stages, seeding density of the cells, and medium supplements ([Figure 2](#fig2){ref-type="fig"}A). A cell cluster exhibiting independent contraction activity was counted as one BCC. Total numbers of BCCs generated in the culture were recorded on day 2 of differentiation regardless of their size.

Firstly, we evaluated the effect of coating materials on plates, including fibrin gel (FG), poly-L-lysine (PLL), gelatin (GEL), feeder ZF4 cells (ZF4), or control (none), on cardiomyocyte differentiation efficiency from embryonic cells at the oblong stage by comparing the number of BCCs generated per embryo in each group. Results showed that ZF4 cell co-culture was the most efficient for BCC generation, and both PLL and GEL groups produced greater numbers of BCCs than the control group ([Figure 2](#fig2){ref-type="fig"}B).

Secondly, we compared BCC generation efficiency of the embryonic cells seeding at different developmental stages, including 256-cell, high, oblong, dome, 30% epiboly, 50% epiboly, and 70% epiboly, on gelatin-coated plates to determine an optimum stage for cardiomyocyte differentiation. Embryonic cells at the oblong stage showed the greatest efficiency for cardiomyocyte generation in comparison with the other stages (p \< 0.01; [Figure 2](#fig2){ref-type="fig"}C).

Thirdly, since seeding density of embryonic stem-like cells altered their fates for differentiation in a previous study ([@bib27]), we investigated the effect of seeding density of the cells on their cardiomyocyte induction potential. We observed that cells seeding at a density ranging from 1--2 × 10^4^ cells/cm^2^ had higher BCC yield than the other densities (p \< 0.01; [Figure 2](#fig2){ref-type="fig"}D). High density of primary embryonic cells led to the formation of large cell aggregates, which eventually did not differentiate into cardiomyocytes. Thus, the seeding density of embryonic cells is important for efficient BCC generation.

Finally, we evaluated the effect of supplemental factors on the cardiomyocyte induction, including epidermal growth factor (EGF), zebrafish embryonic extract (ZEE), ZF4 cell-conditioned medium (ZF4 CM), and INSULIN. On removal of a single factor from the recipe of the medium in each group, INSULIN affected the BCC generation efficiency, ZEE or ZF4 CM deduction also decreased the efficiency, while EGF did not ([Figure 2](#fig2){ref-type="fig"}E). INSULIN addition had a dose-dependent effect on the induction efficiency at concentrations of 0, 10, 25, and 50 μg/mL with a greater efficiency when added at the beginning of the induction ([Figures 2](#fig2){ref-type="fig"}F and 2G). Thus, maximum induction efficiency for cardiomyocyte differentiation can be achieved using the combination of oblong-stage embryonic cells at a density from 1--2 × 10^4^ cells/cm^2^, ZF4 feeder cells, and supplements of ZEE, ZF4 CM, and INSULIN. Using this condition, we observed that the BCCs can present within as early as 28 hr of the induction, and the number of BCCs reached a peak on day 2 (8.4 ± 0.6 BCCs per embryo) ([Figures 2](#fig2){ref-type="fig"}H and 2I; [Movie S1](#mmc2){ref-type="supplementary-material"}). The contraction activity was decreased in some BCCs after 8 days of differentiation while the beats were retained in the others for up to 20 days ([Figure 2](#fig2){ref-type="fig"}H). In addition, cardiac marker Myl7 can be detected in these induced cardiomyocytes from *myl7*:*EGFP* transgenic zebrafish ([Figure 2](#fig2){ref-type="fig"}J). These results indicate that this culture process for cardiomyocyte induction is close to in vivo cardiogenesis timing (24 hpf) in zebrafish ([@bib34]).

Nrg1 has been recently reported as a cardiac mitogen, which promoted endogenous heart regeneration in zebrafish ([@bib20]). To explore the regenerative responses of cardiomyocytes to the mitogen, we investigated the effects of NRG1 treatment on formation and proliferation of zebrafish cardiomyocytes using our culture system in vitro. We observed that efficiencies of generating BCCs from embryonic cells were increased linearly (R^2^ = 0.91) with an increasing amount of NRG1 ([Figure 2](#fig2){ref-type="fig"}K). NRG1 significantly promoted the cardiac differentiation of embryonic cells on day 2 (p \< 0.01) and day 3 (p \< 0.05; [Figure 2](#fig2){ref-type="fig"}L). In addition, NRG1-treated BCCs showed more nuclei than control BCCs, and numbers of nuclei NRG1-treated BCCs increased from day 2 to day 3 ([Figure 2](#fig2){ref-type="fig"}M). These data suggested that Nrg1 promoted proliferation and formation of cardiomyocytes in zebrafish.

Morphology and Contractile Kinetics of Beating Cell Clusters {#sec2.3}
------------------------------------------------------------

For morphological observations, we performed induction culture using the optimal condition mentioned above, and observed morphological changes in the BCCs at different stages ([Figure 3](#fig3){ref-type="fig"}A). Most of BCCs on days 1 and 2 were irregular spheres, fusiform, or long-shuttle in shape ([Figures 3](#fig3){ref-type="fig"}B and 3C). Afterward the BCCs gradually spread, their contracting area enlarged ([Figures 3](#fig3){ref-type="fig"}D and 3E), and they finally became rhythmically beating cell sheets, which lasted for more than 20 days ([Figures 3](#fig3){ref-type="fig"}F and 3G).

We then measured the contraction/relaxation velocity and amplitude of BCCs. Contraction velocity was higher than the relaxation velocity (8.2 ± 0.7 μm/s versus 5.1 ± 0.3 μm/s; [Figure 3](#fig3){ref-type="fig"}H), while their contractile amplitude was maintained at 1.8 ± 0.1 μm for 20 days ([Figure 3](#fig3){ref-type="fig"}I). These BCCs beat slowly during the first day (29.6 ± 1.3 bpm) and then faster at a rate of 59.0 ± 0.5 bpm ([Figure 3](#fig3){ref-type="fig"}J). These kinetics features are comparable with those of the cardiomyocytes derived from human stem cells ([@bib3], [@bib24]).

Cardiac Marker Expression and Sarcomere Formation {#sec2.4}
-------------------------------------------------

To investigate gene-expression patterns of the embryonic cells during differentiation induction, we analyzed four types of markers for pluripotency, germ layers, cardiac progenitors, and cardiomyocytes. RT-PCR showed that *klf17* and *nanog* were expressed only for the first 2 days, while *pou5f3* expression gradually decreased. For the germ layer markers, ectoderm genes (*sox2, nestin*, and *pax6a*) started to express on day 4 and then endoderm (*sox17*, and *foxa2*) genes followed their expression, whereas expression of mesoderm marker *ta* was detectable from days 0--16 ([Figure 3](#fig3){ref-type="fig"}K). We further investigated marker expressions of cardiac progenitors and cardiomyocytes. The genes for cardiac progenitors (*gata4, tbx5a*, and *nkx2.5*) started to express from day 1, while cardiomyocyte markers (*tnnt2a, myh6*, and *vmhc*) appeared on the second day except for *myl7*, which was expressed from day 1 ([Figure 3](#fig3){ref-type="fig"}K). Indeed these makers (*nkx2.5* and *tnnt2a*) were not expressed during early stages of embryogenesis ([Figure 1](#fig1){ref-type="fig"}C). These results indicated that cardiac progenitor cells and cardiomyocytes had generated and that pluripotency decreased during cardiomyocyte induction.

To characterize sarcomere formation, we used *myl7:EGFP* transgenic primary embryonic cells for BCC generation, which enabled us to evaluate the expression of cardiac marker *myl7* during cardiomyocyte differentiation. Immunostaining of α-skeletal muscle actin (Acta1, a marker for I bands of sarcomeres) showed continuous dot-like signals in BCCs on day 2, indicating an early phase of sarcomeric assembly. Continuous band-like signals could be observed in some BCCs at day 6, and a typical pattern of sarcomeric I bands was detected in some spread BCCs at days 9 and 14 ([Figure 3](#fig3){ref-type="fig"}L), indicating mature sarcomere formation. However, mature and well-organized sarcomeres were scarcely detected in ball-like BCCs (upper panel of day 9 in [Figure 3](#fig3){ref-type="fig"}L). These data demonstrated that the BCCs derived from primary embryonic cells expressed cardiac markers of both progenitor cells and cardiomyocytes and presented a dynamic sarcomeric maturation process within the induced cardiomyocytes.

BCCs Display Functional Electrophysiological Features {#sec2.5}
-----------------------------------------------------

To address the question of whether the generated BCCs have functional features of cardiomyocytes, we first recorded their spontaneous whole-cell action potentials (APs) using a patch-clamp amplifier. Three typical AP patterns, namely ventricular-like, nodal-like, and atrial-like, were observed in the BCCs ([Figure 4](#fig4){ref-type="fig"}A). The BCCs with ventricular-like APs exhibited a rapid upstroke and a distinct plateau phase. Nodal-like APs showed a typical phase 4 of pacemaker potential, which depolarized slowly up to the threshold potential followed by a more gradual upstroke and then a rapid repolarization phase. Atrial-like BCCs indicated a fast depolarization pattern similar to that of ventricular-like BCCs, but with no plateau phase during their repolarization. No membrane potential upstrokes were detected in nonbeating embryonic cells. Among tested BCCs, 81% cells were ventricular-like, 13% were nodal-like, and 6% were atrial-like subtype cardiomyocytes ([Figure 4](#fig4){ref-type="fig"}B). All three subtypes had similar AP amplitude (APA; [Figure 4](#fig4){ref-type="fig"}C). However, the ventricular-like subtype showed longer AP durations as indicated in both APD~50~ (AP duration at 50% repolarization) and APD~90~ than both nodal-like and atrial-like subtype cardiomyocytes ([Figures 4](#fig4){ref-type="fig"}D and 4E). Thus, the induction can generate three typical subtypes of cardiomyocytes with distinct cardiac spontaneous AP patterns.

Next, we evaluated the response of the BCCs to current pulse stimulation at an increasing frequency. The tested cells exhibited shortened APD as the frequency of stimulation increased (1, 2, and 3 Hz) ([Figure 5](#fig5){ref-type="fig"}A). Both APD~50~ and APD~90~ declined when stimulated at 3 Hz, and 2-Hz stimulation reduced APD~90~ of BCCs compared with 1-Hz stimulation ([Figure 5](#fig5){ref-type="fig"}B). Therefore, induced cardiomyocytes were able to efficiently respond to current pulse stimulation.

Because response to epinephrine (EPI) is an essential feature of the heart, we then tested whether BCCs could respond to epinephrine treatment. An accelerating frequency of membrane potential was detected upon EPI treatment ([Figures 5](#fig5){ref-type="fig"}C and 5D). Correspondingly, both APD~50~ and APD~90~ were reduced by the treatment ([Figures 5](#fig5){ref-type="fig"}E and 5F), indicating functional existence of β-adrenergic receptors in the BCCs.

As tetrodotoxin (TTX) can block cellular Na^+^ channels, we finally examined whether induced cardiomyocytes possessed TTX-sensitive Na^+^ channels. AP records showed that TTX had no effect on APA but reduced AP frequencies ([Figures 5](#fig5){ref-type="fig"}G and 5H). Neither APD~50~ nor APD~90~ of the BCCs was affected by the TTX treatment ([Figures 5](#fig5){ref-type="fig"}I and 5J). These data demonstrated that TTX-sensitive Na^+^ channels were functional in BCCs.

Discussion {#sec3}
==========

Given the physiological similarities of cardiomyocytes between zebrafish and human ([@bib10], [@bib44]), the zebrafish has emerged as an outstanding system for studying cardiac development and regeneration, performing cardiac-associated phenotypic screening, testing cardiotoxicity, and modeling heart diseases ([@bib1], [@bib2], [@bib4], [@bib31], [@bib33], [@bib40], [@bib45]). In the present study, we have determined the pluripotency window of zebrafish embryos by analyzing gene-expression patterns of pluripotency factors in combination with markers of three germ layers. Based on the pluripotency, we established a rapid and efficient method for cardiomyocyte generation in vitro from primary embryonic cells. The induced cardiomyocytes differentiated into specific cardiomyocyte subtypes including ventricular, atrial, and pacemaker cells. We then characterized the contractile kinetics and electrophysiological functions of these in vitro generated cardiomyocytes. The system depicts a new paradigm of cardiomyocyte differentiation from primary embryonic cells ([Figure 6](#fig6){ref-type="fig"}).

The pluripotency of zebrafish embryos remains elusive. Several stem-like cell lines have been derived from oblong-stage embryos ([@bib18], [@bib27], [@bib28]). Blastomere or cultured embryonic cell transplant studies showed the existence of uncommitted cells in gastrula ([@bib18], [@bib26]). It is possible in zebrafish that some embryonic cells remain in a pluripotent state when the mesoderm starts to be specified in midblastula embryos. Indeed, recent single-cell analysis showed that genome methylation levels are quite different from zygotes to blastula in mammals ([@bib22]), indicating a differential pluripotent state among embryonic cells. In addition, few studies have addressed when zebrafish embryos start to exit the pluripotent state. Monitoring dynamic expression of pluripotency-associated markers in different stages of embryos may be a better solution. Nevertheless, pluripotency markers widely used in mammals, such as SOX2, did not serve well for zebrafish in this or previous ([@bib51]) studies. Recent studies showed that pluripotency factors Pou5f3 and Nanog played crucial roles in pluripotency establishment in zebrafish. Both *pou5f3* and *nanog* are expressed maternally and zygotically ([@bib59], [@bib66]), playing key roles in activation of zygotic genes in zebrafish ([@bib36], [@bib38]). The zygotic genome is transcriptionally quiescent after fertilization until the first large wave of zygotic transcript activation and maternal transcript degradation, which is termed maternal-to-zygotic transition ([@bib58]). The zygotic genome activation initiates at the 1,000-cell stage (3 hpf) in zebrafish ([@bib41]) and at the 2-cell stage (24 hpf) in mouse ([@bib23]). For zygotic genome activation in zebrafish, Nanog, Pou5f3, and Soxb1 bind to and activate global expression of many embryonic genes including miR-430, which is responsible for maternal RNA clearance ([@bib36], [@bib37], [@bib38]). Zygotic genome activation in mammals is probably different from that in zebrafish, as establishment of totipotency does not depend on OCT4A in mice ([@bib64]). Three germ layers emerge after gastrulation in mice. However, a mesoderm marker (*ta*) starts to express as early as the oblong stage (midblastula) in zebrafish, indicating a much earlier differentiation of embryogenesis in zebrafish than in mouse. This was confirmed by the decrease in efficiency of cardiomyocyte generation when late-blastula and gastrula embryonic cells were used for induction in our study. Therefore, pluripotency of embryonic cells in zebrafish cannot be determined only by pluripotency factors such as Pou5f3 and Nanog. The onset of germ layer differentiation is another critical factor. Thus, based on expression patterns of markers of both pluripotency and germ layers, we determine the pluripotent window of embryogenesis in zebrafish as from zygotic genome activation to a brief moment after the oblong stage (less than 2 hr), which is a very narrow period for pluripotency maintenance in the cell priming of mesoderm differentiation.

A better understanding of pluripotent state of zebrafish embryos allows us to accurately induce differentiation to cardiomyocytes from primary embryonic cells. A central feature of our method is the use of a combination of appropriate conditions including cell density, ZF4 feeder cells, and supplements to facilitate the cardiomyocyte induction, in addition to utilizing pluripotency characteristics. This induction process is similar to in vivo cardiogenesis timing (24 hpf) in zebrafish ([@bib34]). Among the supplements (ZEE, ZF4 CM, and INSULIN), INSULIN is an essential factor. Indeed, INSULIN and its receptor are both maternally and zygotically expressed, and knockdown of *insulin* receptor resulted in cardiac abnormalities in zebrafish, suggesting that INSULIN plays important roles in cardiogenesis ([@bib46], [@bib61]). Treatment of mouse embryonic stem cells with INSULIN or insulin-like growth factor (IGF) 1 or 2 promoted proliferation of mesodermal cells and cardiomyocyte generation via the PI3K/AKT/TOR signaling pathway ([@bib16]). IGF signaling also promotes a continued expansion of cardiac progenitor cells derived from human PSCs ([@bib9]).

Another feature of the induction system is that the induced cardiomyocytes have typical contractile kinetics and electrophysiological characteristics. Spontaneous beats of cardiomyocytes are driven by depolarization-repolarization cycles of the cell membrane potential. AP patterns of in vitro generated BCCs in this study resemble those of ventricles, atria, or pacemakers in adult zebrafish hearts ([@bib44], [@bib60]), and are also similar to those of human ([@bib44]). Functional properties of cardiomyocytes can further be manifested by rate adaptation tests and drug treatments. In rate adaptation tests, BCCs adapted to the stimulations at increasing frequencies by shortening their APD, which is consistent with zebrafish ventricular myocytes ([@bib10]) and human PSC-derived cardiomyocytes ([@bib25], [@bib39], [@bib69]). Another property is functional response to β-adrenergic stimulations, which is comparable in zebrafish hearts ([@bib47], [@bib56]) and human PSC-derived cardiomyocytes ([@bib69]), suggesting the presence of functional β-adrenergic receptors in the BCCs. A more important feature is the presence of a sodium channel in the induced cardiomyocytes, as revealed by TTX response. A similar effect of TTX on the induced cardiomyocytes was also observed in adult hearts of zebrafish ([@bib15], [@bib44]).

Robust regenerative ability in adult cardiomyocytes makes zebrafish an ideal model for studying heart regeneration ([@bib31], [@bib49], [@bib50]). Since cardiomyocyte proliferation is a key step of zebrafish heart regeneration ([@bib31]), it is important to discover essential components that trigger or promote this process. An efficient in vitro culture of adult zebrafish cardiomyocytes has been established recently ([@bib54]). In this study, we have provided a detailed method of in vitro cardiomyocyte differentiation from embryonic cells. Differentiated cardiomyocytes are functional and capable of recapitulating proliferative responses to mitogens. Generation and proliferation of cardiomyocytes were both substantially enhanced by NRG1 treatment, consistent with previous studies in mammalian and zebrafish heart regeneration ([@bib8], [@bib20]). Combining utilization of transgenic fish lines that specifically express fluorescent protein in cardiomyocyte nuclei, our system possesses potential in exploring novel mitogens or factors involved in heart regeneration. The advantage of our system is that it is primed to generate cardiomyocytes from lethal mutant lines that cannot survive to adulthood. As long as the mutant embryos remain viable at the oblong stage, generation of differentiated cardiomyocytes can be achieved by using the protocols provided herein, and thus gene functional studies can be carried out based on regenerative responses of the mutant cardiomyocytes. Therefore, we have determined an alternative way to gain insight into heart regeneration mechanisms in zebrafish. The primary embryonic cell-based system can be used to perform high-throughput screening of factors for heart study not merely limited to small molecules ([@bib29], [@bib67]) to also include nucleic acids, proteins and lipids, and so forth, which is difficult to achieve in the zebrafish in vivo screening model. The system is also promising for the dissection of pathways of cardiac development and regeneration in lethal mutants.

Experimental Procedures {#sec4}
=======================

See also [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.

Zebrafish, Cells, and Antibodies {#sec4.1}
--------------------------------

All animal experiments and methods were performed in accordance with the relevant approved guidelines and regulations, as well as under the approval of the Ethics Committee of Wuhan University. The wild-type AB zebrafish (*Danio rerio*), the *Tg* (*myl7:EGFP*) transgenic line, and ZF4 cell line CRL-2050 were used in this study. Antibodies used in the immunofluorescence assay were polyclonal antibody anti-Acta1 (1:10 dilution; AP14779, Abgent) and Cy3-conjugated secondary antibody (1:100 dilution; E031620-01, EarthOx).

Isolation of Primary Embryonic Cells {#sec4.2}
------------------------------------

Zebrafish embryos were bleached in 0.003% sodium hypochlorite for 2 min, rinsed with sterilized 0.5× E2 medium, and dechorionated in 0.1 mg/mL pronase E (P5147, Sigma-Aldrich) with occasional swirling, then rinsed with sterilized 0.5× E2 again. Embryonic cells were cultured in 24-well plates. The cells seeded in each well were isolated from 40--50 oblong embryos to ensure a consistent density of cells among wells.

Induction of Cardiomyocyte Differentiation {#sec4.3}
------------------------------------------

Embryonic cells at oblong stage or other stages were induced for cardiomyocyte differentiation at 28.5°C. Cells were plated onto plates at different cell densities ranging from 1 to 4.5 × 10^4^ cells/cm^2^. ZF4 cells (zebrafish embryonic fibroblast cell line) were cultured as feeder cells at a density of 2 × 10^4^ cells/cm^2^. Complete medium used for cardiomyocyte differentiation from primary embryonic cells was the basal medium supplemented with 1% fish serum, 85 μg protein/mL ZEE, 30% conditioned medium (ZF4 CM), 25 μg/mL INSULIN (I5500, Sigma-Aldrich), and 50 ng/mL EGF (315-09, Pepro Tech). During evaluating proliferative responses of BCCs to mitogens, recombinant NRG1 (11609H01H50, Thermo Fisher Scientific) was supplemented to culture the oblong embryonic cells at a concentration of 0, 50, 100, 200, 500 and 1,000 ng/mL, respectively. BCCs emerging in the culture were recorded under an inverted microscope (Leica DM IRB).

RT-PCR {#sec4.4}
------

Total RNAs of embryonic cells at different stages were isolated using TRIzol reagent (15596026, Thermo Fisher). Extracted RNAs were treated with DNase treatments (M610A, Promega). The first strands of cDNAs were synthesized following the protocol (M170A, Promega). Primer sequences and PCR conditions are listed in [Table S1](#mmc1){ref-type="supplementary-material"}.

Contraction Kinetics {#sec4.5}
--------------------

Videos of BCCs were recorded with a camera equipped on an inverted microscope (Leica DM IRB). Images were extracted from the videos at a frequency of 10 frames per second. A contracting site was tracked through a series of images. x and y coordinates of the sites were recorded using ImageJ software (<http://imagej.nih.gov/ij/>). Contraction amplitudes were calculated based on the coordinates of the contracting site before and after the contraction. The contraction or relaxation velocity was calculated by dividing contraction or relaxation distance by the duration, respectively.

Electrophysiology {#sec4.6}
-----------------

BCCs were picked up by a glass capillary connected to a mouth pipette at day 2 of differentiation, replated onto coverslips coated with PLL, and maintained in complete cardiomyocyte differentiation medium before recording the AP. AP activities of cardiomyocytes were recorded in a whole-cell patch-clamp configuration using a HEKA EPC10 amplifier driven by PatchMaster software (HEKA).
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![Pluripotency Timing during Embryogenesis in Zebrafish\
(A) Representative morphology of early embryos at 256-cell, high, oblong, sphere, dome, 30%-epiboly, 50%-epiboly, and 70%-epiboly stages. hpf, hours post fertilization. Scale bar, 250 μm.\
(B) Morphology of isolated embryonic cells from different stages. Asymmetric spread of cytoplasm was observed in all stages (lower panel). Scale bar, 50 μm.\
(C) RT-PCR analysis of gene expression patterns in different stages of the embryos. Primer sequences and PCR conditions are listed in [Table S1](#mmc1){ref-type="supplementary-material"}. NTC, no template control.](gr1){#fig1}

![Factors and Conditions that Affect Cardiomyocyte Differentiation Efficiency from Primary Embryonic Cells\
(A) Selected factors affecting BCC (beating cell clusters) generation efficiency at different experimental steps, including stage of embryos, seeding density of embryonic cells, factors supplemented in the medium, and culture-ware coatings.\
(B) Effect of culture-ware coatings on BCC generation efficiency. Oblong-stage embryonic cells were used for cardiomyocyte differentiation. Coating materials, fibrin gel (FG), poly-L-lysine (PLL, 0.1 mg/mL), gelatin (GEL, 2 mg/mL), ZF4 cells (ZF4, 2 × 10^4^ cells/cm^2^), and control (None). Experiment repeated once, n = 3 wells of cells/group.\
(C) Effect of developmental stages of embryonic cells on BCC generation efficiency. The culture plates were coated with gelatin. The dashed line indicates the comparison between 256-cell and 50% epiboly. Five independent experiments, n = 3--20 wells of cells/group.\
(D) Effect of seeding density of embryonic cells on BCC generation efficiency. Embryonic cells from oblong stage were seeded in gelatin-coated plates at different cell densities during in vitro cardiomyocyte differentiation. Eight independent experiments, n = 3--10 wells of cells/group. In the following investigations (E--G), oblong-stage cells were seeded at a density of 1--2 × 10^4^ cells/cm^2^ in gelatin-coated plates during in vitro cardiomyocyte differentiation.\
(E) Evaluating effect of supplementation of epidermal growth factor (EGF), zebrafish embryonic extract (ZEE), ZF4 cell-conditioned medium (ZF4 CM), INSULIN (INS), or control (complete medium) on BCC generation efficiency by removing single factor. Experiment repeated once, n = 3 wells of cells/group.\
(F) Effect of INSULIN supplemental doses on BCC generation efficiency at days 0, 1, and 2 of culture. INSULIN was supplemented at a concentration of 0, 10, 25, or 50 μg/mL. Experiment repeated once, n = 3 wells of cells/group.\
(G) Effect of INSULIN addition (50 μg/mL) at 0, 1, 2, and 4 hr post seeding cells on BCC generation efficiency. Experiment repeated once, n = 3 wells of cells/group.\
(H) Numbers of BCCs per embryo at different days of differentiation under optimum conditions from (B--G). Two independent experiments, n = 3--4 wells of cells/group.\
(I) Representative image of efficient BCC generation at day 2 of differentiation. Dashed lines, beating areas; dots, contracting sites. The image was extracted from a video ([Movie S1](#mmc2){ref-type="supplementary-material"}). Scale bar, 50 μm.\
(J) EGFP expression driven by *myl7* promoter in *myl7:EGFP* transgenic embryonic cells on day 3 of differentiation. Scale bar, 200 μm.\
(K--M) Effects of NRG1 on cardiomyocyte proliferation using in vitro cardiac differentiation system in zebrafish. (K) A dose-response evaluation of NRG1 for BCC generation (NRG1 at 0, 50, 100, 200, 500 and 1,000 ng/mL). The linear regression line was y = 0.0297x + 5.6657. Two independent experiments, n = 2 wells of cells/group. (L) Effects of NRG1 treatment (100 ng/mL) on BCC formation on days 2, 3, and 4 of differentiation. Three independent experiments, n = 3--8 wells of cells/group. CTR, 0 ng/mL of NRG1. (M) Proliferative effects of NRG1 on cardiomyocytes. Cell culture was stained with Hoechst 33342 prior to observation under an inverted fluorescent microscope. Numbers of nuclei within each BCC (0 or 100 ng/mL of NRG1 treatment) were recorded on days 2, 3, and 4 of differentiation. Two independent experiments, n = 23--66 BCCs/group.\
Data are shown as mean ± SEM. ^∗^p \< 0.05, ^∗∗^p \< 0.01.](gr2){#fig2}

![Morphology and Beating Characteristics of BCCs Differentiated from Primary Embryonic Cells\
(A) Schematic diagram of in vitro differentiation procedures.\
(B--G) Morphology of BCCs at different days of differentiation when co-culturing with ZF4 cells. Dashed lines, contracting area; arrows, contracting directions; Red dots show the sites that were used for track analysis of BCC contractile kinetics in (H) and (I). Scale bar, 20 μm.\
(H and I) Contraction and relaxation velocity (H) and contraction amplitudes (I) of BCCs at different days of differentiation. Three contractions of each BCC pointed by red dots in (B--G) were tracked. Data are shown as mean ± SEM.\
(J) Beating rates of BCCs at day 1--20. Cells were cultured in gelatin-coated plates. Two independent experiments, n = 52--101 BCCs/group. Blue dots show the beating rates of the BCC in (B--G).\
(K) Gene-expression analysis by RT-PCR during cardiomyocyte differentiation of primary embryonic cells. Primer sequences and PCR conditions are listed in [Table S1](#mmc1){ref-type="supplementary-material"}. NTC, no template control.\
(L) Cellular and molecular characteristics of *Tg* (*myl7:EGFP*) BCCs at different stages of differentiation. Early stage, day 2; middle stage, day 6; late stage, days 9 and 14. Cardiomyocytes marker, Myl7 (green); sarcomeres maker, α-skeletal actin (Acta1, red). Enlarged squares indicate the process of sarcomere formation during cardiomyocyte maturation. Nuclei were stained with DAPI (blue). Scale bars, 50 μm.](gr3){#fig3}

![Electrophysiological Characterization of BCCs\
(A) Representative action potential (AP) patterns of three subtypes of cardiomyocytes. AP was recorded by whole-cell patch-clamp method on day 5 of differentiation.\
(B) Proportions of ventricular-like, nodal-like, and atrial-like BCCs.\
(C--E) AP amplitude (APA), AP duration at 50% repolarization (APD~50~), and AP duration at 90% repolarization (APD~90~) in three types of BCCs. Two independent experiments: ventricular-like, n = 22 BCCs; nodal-like, n = 4 BCCs; atrial-like, n = 2 BCCs.\
Data are shown as mean ± SEM.](gr4){#fig4}

![Stimulation Rates Adaptation and Drug Responses of BCCs\
(A) APs of day-5 ventricular-like BCCs were recorded at 5-ms current pulse stimulation at 1, 2, and 3 Hz. All APs were from the same BCC stimulated at 1, 2, and 3 Hz.\
(B) Fractional changes of AP durations at 50% and 90% repolarization. The values were normalized to the values observed at 1-Hz stimulation. Experiment repeated once, n = 5 BCCs.\
(C--J) Effect of adrenergic receptor agonist and Na^+^ channel blocker on spontaneous AP of day-5 BCCs. (C) Representative APs of the BCC before (Pre-EPI) and during (EPI) perfusion of bath solution containing 10 μM adrenergic receptor agonist epinephrine (EPI). (D--F) Fractional changes of beating rates (D), AP durations at 50% repolarization (E), and AP durations at 90% repolarization (F). The values were normalized to the values obtained before EPI applied (Pre-EPI). Experiment repeated once, n = 8 BCCs. (G) Representative APs of the BCC before (Pre-TTX) and during (TTX) perfusion of bath solution containing 10 nM Na^+^ channel blocker tetrodotoxin (TTX). (H--J) Fractional changes of beating rates (H), AP durations at 50% repolarization (I), and AP durations at 90% repolarization (J). The values were normalized to the values obtained before TTX applied (Pre-TTX). Experiment repeated once, n = 4 BCCs.\
Data are shown as mean ± SEM.](gr5){#fig5}

![A Working Model for In Vitro Cardiomyocyte Differentiation from Primary Embryonic Cells in Zebrafish\
A pluripotent window of embryogenesis in zebrafish, from zygotic genome activation to a short moment after the oblong stage (\<2 hr), allows us to efficiently induce the oblong-stage cells to differentiate into functional cardiomyocytes under a combination of optimal conditions. The induced cardiomyocytes can differentiate into specific cardiomyocyte subtypes, including ventricular, atrial, and pacemaker cells.](gr6){#fig6}
